세계의 안검염 시장 보고서(2025년)

Blepharitis Global Market Report 2025

US $ 4,490 ￦ 6,527,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,434,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,341,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

안검염 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 12.2%로 성장할 전망이며, 15억 4,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 개별화 치료접근법의 진보, 편리한 재택치료 옵션에 대한 기호 고조, 환자의식의 향상, 신흥시장으로의 확대, 규제승인의 합리화 등에 기인한다고 생각됩니다. 이 기간에 예상되는 주요 동향에는 강력 펄스광 치료, AI를 활용한 화상 진단, 자동 안검 촬영 시스템, 멀티모달 치료 전략, 생물제제 개발 등 혁신적 치료 출현이 포함됩니다.

아이케어에 대한 의식의 고조는 향후 수년간 안검염 시장의 확대를 촉진할 것으로 예측됩니다. 아이 케어에는, 눈의 건강과 시력의 유지 및 향상을 목적으로 한 다양한 서비스, 치료, 실천이 포함됩니다. 양호한 시력은 개인의 자립, 교육의 달성, 일의 생산성, 삶의 질 전체에 중요한 역할을 하기 때문에 의식의 향상이 필수적입니다. 시력 문제를 방치하면 일상생활이나 학업성적, 일의 효율에 악영향을 미칠 수 있습니다. 안검염 치료는 증상의 조기 발견을 촉진하고, 일관된 눈꺼풀 위생을 장려하며, 적기 치료를 통해 안구건조증, 결막염 등 합병증을 예방함으로써 종합적인 아이케어에 기여합니다. 예를 들면, 2024년 10월, 영국을 거점으로 하는 단체인 AOP(Association of Optometrists : 검안사 협회)는, 영국에서 시력 상실자의 수는 2035년까지 약 280만 명으로 증가할 것으로 예측하고 있으며, 이것은 2022년과 비교해 27% 증가한다고 보고했습니다. 이 때문에 아이케어에 대한 의식의 고조가 안검염 시장의 성장에 크게 기여하고 있습니다.

안검염 시장의 주요 기업은 경쟁을 강화하기 위해 표적 항기생충약이나 혁신적인 안과용 제제 등의 신규 치료의 개발에 주력하고 있습니다. 혁신적인 안과용 제제에는 눈 질환의 치료 효과, 안전성, 환자의 쾌적성을 높이기 위해 설계된 선진적인 약물 전달 시스템과 조성물이 포함됩니다. 예를 들면, 2023년 7월, 미국의 바이오 의약품 회사인 Tarsus Pharmaceuticals Inc.는, 데모덱스 안검염의 치료로서 XDEMVY(로티라넬 점안액) 0.25%의 FDA 승인을 취득했습니다. 이전에는 TP-03으로 알려져 있던 XDEMVY는 데모덱스 안검염의 근본 원인인 데모덱스 진드기를 직접 표적으로 하는 FDA가 승인한 최초이자 유일한 치료입니다. 이번 승인은 833명의 환자가 참여한 2개의 중요한 임상검사(Saturn-1과 Saturn-2)에서 얻은 확실한 임상 데이터에 의해 뒷받침되고 있으며, 위약과 비교하여 현저한 증상의 개선과 높은 목덜미의 완치율이 실증되었습니다. 권장 용량은 1회 1방울을 1일 2회, 6주 동안 점안하는 것입니다. XDEMVY의 인용성은 일반적으로 양호하며, 경도의 시린 듯한 통증과 화끈거림이 가장 많이 보고되고 있는 부작용입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 안검염 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 안검염 시장 : 성장률 분석
• 세계의 안검염 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 안검염 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 안검염 : 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 안검염 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 전안검염
• 후안검염
• 혼합안검염
• 세계의 안검염 시장 : 치료별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 안약
• 인공눈물
• 항생제 요법
• 세계의 안검염 시장 : 진단별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 신체 검사
• 종합 안과 검사
• 기타
• 세계의 안검염 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 전문센터
• 세계의 안검염 시장 : 전안검염별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 포도상구균 안검염
• 지루성 안검염
• 세계의 안검염 시장 : 후안검염별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 마이 폭탄선 기능부전(MGD)
• 술 관련 눈꺼풀
• 세계의 안검염 시장 : 혼합 안검염별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 전안과 후안의 혼합형 안검염
• 만성 혼합 안검염

제7장 지역별 및 국가별 분석

• 세계의 안검염 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 안검염 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 안검염 시장 : 경쟁 구도
• 안검염 시장 : 기업 프로파일
  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Merck & Co Inc.
  • AbbVie Inc.
  • Novartis AG

제31장 기타 주요 기업 및 혁신 기업

• Takeda Pharmaceutical Company Limited
• Viatris Inc.
• Regeneron Pharmaceuticals Inc.
• Bausch Health Companies Inc.
• Sun Pharmaceutical Industries Ltd.
• Thea Pharmaceuticals Ltd
• Harrow Inc.
• URSAPHARM Arzneimittel GmbH
• Tarsus Pharmaceuticals Inc.
• Scope Ophthalmic Ltd
• Santen Pharmaceutical Co Ltd.
• NovaBay Pharmaceuticals Inc.
• InSite Vision Incorporated
• MiBo Medical Group
• Nicox SA

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 안검염 시장(2029년) : 새로운 기회를 제공하는 국가
• 안검염 시장(2029년) : 새로운 기회를 제공하는 부문
• 안검염 시장(2029년) : 성장 전략
  • 시장 동향에 의한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Blepharitis is a common eye disorder characterized by inflammation of the eyelids, typically at the base of the eyelashes. It often leads to symptoms such as redness, itching, crusting, and a gritty or burning feeling in the eyes. This condition is usually chronic and may be caused by bacterial infections, skin disorders like dandruff, or blocked oil glands.

The primary types of blepharitis include anterior blepharitis, posterior blepharitis, and mixed blepharitis. Anterior blepharitis affects the front edge of the eyelid, where the eyelashes grow. Treatment options commonly include eye cleansers, artificial tears, and antibiotic therapy. Diagnosis methods such as physical examinations and comprehensive eye evaluations are employed across various healthcare settings, including hospitals and specialty clinics.

The blepharitis market research report is one of a series of new reports from The Business Research Company that provides blepharitis market statistics, including blepharitis industry global market size, regional shares, competitors with a blepharitis market share, blepharitis market segments, market trends and opportunities, and any further data you may need to thrive in the blepharitis industry. This blepharitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blepharitis market size has grown strongly in recent years. It will grow from $0.86 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 12.5%. The growth during the historic period can be attributed to the rise in eye-related disorders, an aging global population, heightened awareness of ocular hygiene, increased screen time, and a surge in allergic and dermatological conditions.

The blepharitis market size is expected to see strong growth in the next few years. It will grow to $1.54 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to the advancement of personalized treatment approaches, a growing preference for convenient at-home care options, increased patient awareness, expansion into emerging markets, and streamlined regulatory approvals. Key trends expected during this period include the emergence of innovative treatments such as intense pulsed light therapy, AI-powered diagnostic imaging, automated eyelid imaging systems, multi-modal treatment strategies, and the development of biologic drugs.

The growing awareness of eye care is expected to drive the expansion of the blepharitis market in the coming years. Eye care encompasses a variety of services, treatments, and practices designed to preserve and enhance eye health and vision. Increased awareness is essential, as good vision plays a critical role in an individual's independence, educational achievement, work productivity, and overall quality of life. Unaddressed vision problems can negatively impact daily functioning, academic performance, and job efficiency. Managing blepharitis contributes to comprehensive eye care by promoting early detection of symptoms, encouraging consistent eyelid hygiene, and preventing complications such as dry eye and styes through timely treatment. For example, in October 2024, the Association of Optometrists (AOP), a UK-based organization, reported that the number of individuals living with sight loss in the UK is projected to rise to approximately 2.8 million by 2035-a 27% increase compared to 2022. Therefore, increasing awareness around eye care is significantly contributing to the growth of the blepharitis market.

Leading companies in the blepharitis market are emphasizing the development of novel therapies, including targeted anti-parasitic agents and innovative ophthalmic formulations, to strengthen their competitive position. Innovative ophthalmic formulations involve advanced drug delivery systems and compositions designed to enhance treatment efficacy, safety, and patient comfort in managing eye disorders. For example, in July 2023, Tarsus Pharmaceuticals Inc., a US-based biopharmaceutical company, received FDA approval for XDEMVY (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis. Previously known as TP-03, XDEMVY is the first and only FDA-approved therapy that directly targets Demodex mites-the underlying cause of Demodex blepharitis. The approval was supported by robust clinical data from two pivotal trials (Saturn-1 and Saturn-2) involving 833 patients, demonstrating notable symptom improvement and a higher rate of complete collarette cure compared to placebo. The recommended dosage is one drop in each eye twice daily for six weeks. XDEMVY is generally well tolerated, with mild stinging or burning being the most commonly reported side effects.

In July 2023, LianBio, a US-based biotechnology company, entered into a partnership with Tarsus Pharmaceuticals to broaden access to XDEMVY for the treatment of Demodex blepharitis and meibomian gland disease in regions with substantial unmet medical needs. The collaboration aims to leverage strong clinical evidence and address the large patient population requiring effective treatment options. Tarsus Pharmaceuticals Inc. is a US-based pharmaceutical company dedicated to developing innovative therapies, with a strong focus on eye care.

Major players in the blepharitis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Thea Pharmaceuticals Ltd, Harrow Inc., URSAPHARM Arzneimittel GmbH, Tarsus Pharmaceuticals Inc., Scope Ophthalmic Ltd, Santen Pharmaceutical Co Ltd., NovaBay Pharmaceuticals Inc., InSite Vision Incorporated, MiBo Medical Group, and Nicox SA.

North America was the largest region in the blepharitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blepharitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blepharitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blepharitis market consists of revenues earned by entities by providing services such as antibiotic therapy, topical corticosteroids, topical and oral antibiotics, ointments, and eye cleansers. The market value includes the value of related goods sold by the service provider or included within the service offering. The blepharitis market also includes sales of steroid eye drops, ointments, eyelid cleansers, lid scrubs, and warm compress masks. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blepharitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blepharitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blepharitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blepharitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Anterior Blepharitis; Posterior Blepharitis; Mixed Blepharitis
• 2) By Treatment: Eye Cleansers; Artificial Tears; Antibiotic Therapy
• 3) By Diagnosis: Physical Examination; Comprehensive Eye Examination; Other Diagnosis
• 4) By Application: Hospitals; Specialty Centers
• Subsegments:
• 1) By Anterior Blepharitis: Staphylococcal Blepharitis; Seborrheic Blepharitis
• 2) By Posterior Blepharitis: Meibomian Gland Dysfunction (MGD); Rosacea-Associated Blepharitis
• 3) By Mixed Blepharitis: Combination Of Anterior And Posterior Features; Chronic Mixed Blepharitis
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co Inc.; AbbVie Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blepharitis Market Characteristics

3. Blepharitis Market Trends And Strategies

4. Blepharitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blepharitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blepharitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blepharitis Market Growth Rate Analysis
• 5.4. Global Blepharitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blepharitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blepharitis Total Addressable Market (TAM)

6. Blepharitis Market Segmentation

• 6.1. Global Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anterior Blepharitis
• Posterior Blepharitis
• Mixed Blepharitis
• 6.2. Global Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eye Cleansers
• Artificial Tears
• Antibiotic Therapy
• 6.3. Global Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Examination
• Comprehensive Eye Examination
• Other Diagnosis
• 6.4. Global Blepharitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Centers
• 6.5. Global Blepharitis Market, Sub-Segmentation Of Anterior Blepharitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Staphylococcal Blepharitis
• Seborrheic Blepharitis
• 6.6. Global Blepharitis Market, Sub-Segmentation Of Posterior Blepharitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Meibomian Gland Dysfunction (MGD)
• Rosacea-associated Blepharitis
• 6.7. Global Blepharitis Market, Sub-Segmentation Of Mixed Blepharitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combination Of Anterior And Posterior Features
• Chronic Mixed Blepharitis

7. Blepharitis Market Regional And Country Analysis

• 7.1. Global Blepharitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blepharitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blepharitis Market

• 8.1. Asia-Pacific Blepharitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blepharitis Market

• 9.1. China Blepharitis Market Overview
• 9.2. China Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blepharitis Market

• 10.1. India Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blepharitis Market

• 11.1. Japan Blepharitis Market Overview
• 11.2. Japan Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blepharitis Market

• 12.1. Australia Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blepharitis Market

• 13.1. Indonesia Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blepharitis Market

• 14.1. South Korea Blepharitis Market Overview
• 14.2. South Korea Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blepharitis Market

• 15.1. Western Europe Blepharitis Market Overview
• 15.2. Western Europe Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blepharitis Market

• 16.1. UK Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blepharitis Market

• 17.1. Germany Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blepharitis Market

• 18.1. France Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blepharitis Market

• 19.1. Italy Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blepharitis Market

• 20.1. Spain Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blepharitis Market

• 21.1. Eastern Europe Blepharitis Market Overview
• 21.2. Eastern Europe Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blepharitis Market

• 22.1. Russia Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blepharitis Market

• 23.1. North America Blepharitis Market Overview
• 23.2. North America Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blepharitis Market

• 24.1. USA Blepharitis Market Overview
• 24.2. USA Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blepharitis Market

• 25.1. Canada Blepharitis Market Overview
• 25.2. Canada Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blepharitis Market

• 26.1. South America Blepharitis Market Overview
• 26.2. South America Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blepharitis Market

• 27.1. Brazil Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blepharitis Market

• 28.1. Middle East Blepharitis Market Overview
• 28.2. Middle East Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blepharitis Market

• 29.1. Africa Blepharitis Market Overview
• 29.2. Africa Blepharitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blepharitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blepharitis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blepharitis Market Competitive Landscape And Company Profiles

• 30.1. Blepharitis Market Competitive Landscape
• 30.2. Blepharitis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Blepharitis Market Other Major And Innovative Companies

• 31.1. Takeda Pharmaceutical Company Limited
• 31.2. Viatris Inc.
• 31.3. Regeneron Pharmaceuticals Inc.
• 31.4. Bausch Health Companies Inc.
• 31.5. Sun Pharmaceutical Industries Ltd.
• 31.6. Thea Pharmaceuticals Ltd
• 31.7. Harrow Inc.
• 31.8. URSAPHARM Arzneimittel GmbH
• 31.9. Tarsus Pharmaceuticals Inc.
• 31.10. Scope Ophthalmic Ltd
• 31.11. Santen Pharmaceutical Co Ltd.
• 31.12. NovaBay Pharmaceuticals Inc.
• 31.13. InSite Vision Incorporated
• 31.14. MiBo Medical Group
• 31.15. Nicox SA

32. Global Blepharitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blepharitis Market

34. Recent Developments In The Blepharitis Market

35. Blepharitis Market High Potential Countries, Segments and Strategies

• 35.1 Blepharitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blepharitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blepharitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료